MBX vs. ASST
MBX (MBX Biosciences, Inc) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. MBX operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past year, MBX returned 311.78% vs -85.81% for ASST. At a 0.13 correlation, their price movements are largely independent.
Performance
MBX vs. ASST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MBX achieves a 31.86% return, which is significantly higher than ASST's 4.61% return.
MBX
- 1D
- 3.74%
- 1M
- 34.25%
- YTD
- 31.86%
- 6M
- 50.14%
- 1Y
- 311.78%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ASST
- 1D
- -2.22%
- 1M
- -2.22%
- YTD
- 4.61%
- 6M
- -5.95%
- 1Y
- -85.81%
- 3Y*
- -58.37%
- 5Y*
- —
- 10Y*
- —
MBX vs. ASST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MBX MBX Biosciences, Inc | 31.86% | 71.13% | -19.87% |
ASST Asset Entities Inc. Class B Common Stock | 4.61% | 50.46% | -74.18% |
Correlation
The correlation between MBX and ASST is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024 | 0.13 |
Fundamentals
MBX:
$1.94B
ASST:
$951.57M
MBX:
-$2.30
ASST:
-$25.54
MBX:
$0.00
ASST:
$5.73M
MBX:
-$160.00K
ASST:
-$7.43M
MBX:
-$96.31M
ASST:
-$304.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MBX vs. ASST — Risk / Return Rank
MBX
ASST
MBX vs. ASST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MBX Biosciences, Inc (MBX) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MBX | ASST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.85 | ||
| Sortino ratioReturn per unit of downside risk | +4.53 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 0.93 | +0.51 |
| Calmar ratioReturn relative to maximum drawdown | 8.35 | -0.90 | +9.25 |
| Martin ratioReturn relative to average drawdown | 15.95 | -1.09 | +17.04 |
Loading charts...
Drawdowns
MBX vs. ASST - Drawdown Comparison
The maximum MBX drawdown since its inception was -77.71%, smaller than the maximum ASST drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for MBX and ASST.
Loading charts...
Drawdown Indicators
| MBX | ASST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.71% | -98.78% | +21.07% |
Max Drawdown (1Y)Largest decline over 1 year | -37.60% | -95.98% | +58.38% |
Max Drawdown (3Y)Largest decline over 3 years | — | -97.25% | — |
Current DrawdownCurrent decline from peak | -3.59% | -97.37% | +93.78% |
Average DrawdownAverage peak-to-trough decline | -34.65% | -90.42% | +55.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.65% | 78.96% | -59.31% |
Volatility
MBX vs. ASST - Volatility Comparison
The current volatility for MBX Biosciences, Inc (MBX) is 23.18%, while Asset Entities Inc. Class B Common Stock (ASST) has a volatility of 24.51%. This indicates that MBX experiences smaller price fluctuations and is considered to be less risky than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MBX | ASST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.18% | 24.51% | -1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 60.53% | 81.33% | -20.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 135.43% | 162.88% | -27.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 118.99% | 322.03% | -203.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 118.99% | 322.03% | -203.04% |
Dividends
MBX vs. ASST - Dividend Comparison
Neither MBX nor ASST has paid dividends to shareholders.
Financials
MBX vs. ASST - Financials Comparison
This section allows you to compare key financial metrics between MBX Biosciences, Inc and Asset Entities Inc. Class B Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MBX and ASST have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASST has higher volatility (24.51%) compared to MBX (23.18%). In terms of maximum drawdown, MBX dropped -77.71% vs ASST's -98.78%.
MBX currently has the higher Sharpe Ratio (2.32 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MBX and ASST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer